PHARMACEUTICALS - Active Products
Please click on the name of the product to see the details.
Formulation / Dosage : tablet 50 / 100 mg Therapeutical Use / ATC Code : Anti-diabetic; A 10B Originator / Tradename : Bayer / Glucobay® Availability: SOLD Dossier/Status Report for Acarbose
Formulation / Dosage : tablet 5 / 10mg Therapeutical Use / ATC Code : Calcium Channel blocker; C 8C Originator / Tradename : Pfizer / Norvasc® Availability: SOLD Dossier/Status Report for Amlodipine Besylate
Formulation / Dosage : f.c. tablet 1 mg Therapeutical Use / ATC Code : Anticancer; L 2B Originator / Tradename : A. Zeneca/ Arimidex® Availability: SOLD Dossier/Status Report for Anastrozole
Formulation / Dosage : inj. solution 10 mg / ml Therapeutical Use / ATC Code : Muscle relaxant; M 3A Originator / Tradename : GSK / Tracrium® Availability: SOLD Dossier/Status Report for Atracurium Besylate
Formulation / Dosage : f.c. tablet 50 mg Therapeutical Use / ATC Code : Antiandrogen; L 2B Originator / Tradename : Astra Zeneca / Casodex® Availability: SOLD Dossier/Status Report for Bicalutamide
Formulation / Dosage : nasal spray 50, 100, 200 I.U. Therapeutical Use / ATC Code : Calcium regulator, H 5B Originator / Tradename : Novartis / Miacalcic® Availability: SOLD Dossier/Status Report for Calcitonin
Formulation / Dosage : dry substance 0.5 / 1 / 2 g Therapeutical Use / ATC Code : Antibacterial; J 1D Originator / Tradename : HMR / Claforan® Availability: SOLD Dossier/Status Report for Cefotaxime Sodium
Formulation / Dosage : dry substance 0.5 / 1 / 2 g Therapeutical Use / ATC Code : Antibacterial; J 1D2 Originator / Tradename : GSK / Fortum® Availability: SOLD Dossier/Status Report for Ceftazidime Pentahydr.
Formulation / Dosage : dry substance 0.5 / 1 / 2 g Therapeutical Use / ATC Code : Antibacterial; J 1D Originator / Tradename : Roche / Rocephin® Availability: SOLD Dossier/Status Report for Ceftriaxone Sodium
Formulation / Dosage : f.c. tablet 200 / 400 mg Therapeutical Use / ATC Code : Antihypertensive; C 7A Originator / Tradename : RPR / Selectol® Availability: AVAILABLE Dossier/Status Report for Celiprolol
Formulation / Dosage : tablet 2.5 / 5 / 10 / 20 mg Therapeutical Use / ATC Code : Antihypertensive; C 9A Originator / Tradename : MSD / Xanef® Availability: AVAILABLE Dossier/Status Report for Enalapril
Formulation / Dosage : trans-dermal patch 25 / 50 / 75 / 100 µg / h Therapeutical Use / ATC Code : Narcotic analgesic;N 2A Originator / Tradename : J&J / Duragesic® Availability: SOLD Dossier/Status Report for Fentanyl
Formulation / Dosage : f.c. tablet 5 mg Therapeutical Use / ATC Code : Benign prostatic hyperplasia; G 4C Originator / Tradename : MSD / Proscar® Availability: AVAILABLE Dossier/Status Report for Finasteride
Formulation / Dosage : capsule 50 / 100 / 150 / 200 mg Therapeutical Use / ATC Code : Antifungal; J 2A Originator / Tradename : Pfizer / Diflucan® Availability: SOLD Dossier/Status Report for Fluconazole
Formulation / Dosage : inf. solution 2 mg / ml in 50 / 100 / 200 ml Therapeutical Use / ATC Code : Antifungal; J 2A Originator / Tradename : Pfizer / Diflucan® Availability: SOLD Dossier/Status Report for Fluconazole
Formulation / Dosage : tablet 250 mg Therapeutical Use / ATC Code : Antiandrogen;L 2B Originator / Tradename : Schering / Fugerel® Availability: AVAILABLE Dossier/Status Report for Flutamide
Formulation / Dosage : vial 5 / 10 / 15 / 20 / 30 / 100 ml Therapeutical Use / ATC Code : NMR Contrast Medium; T 1E Originator / Tradename : Schering / Magnevist® Availability: SOLD Dossier/Status Report for Gadopentetic Acid
Formulation / Dosage : tablet 75µg / 30 µg / 20 µg Therapeutical Use / ATC Code : Contraceptive G 3A Originator / Tradename : Schering / Meliane® / Femovan® Availability: AVAILABLE Dossier/Status Report for Gestodene / Ethinylestradiol
Formulation / Dosage : tablet 25 / 50 / 100 / 200 mg dispers. tablet 2 / 5 / 25 / 50 / 100 / 200 mg Therapeutical Use / ATC Code : Antiepileptic, N 3A Originator / Tradename : Glaxo / Lamictal® Availability: SOLD Dossier/Status Report for Lamotrigine
Formulation / Dosage : f.c. tablet 2,5 mg Therapeutical Use / ATC Code : Anticancer; L 2B Originator / Tradename : Novartis / Femara® Availability: AVAILABLE Dossier/Status Report for Letrozole
Formulation / Dosage : tablet 2.5 / 5 / 10 / 20 mg Therapeutical Use / ATC Code : Antihypertensive; C 9A Originator / Tradename : MSD / Acerbon® Availability: AVAILABLE Dossier/Status Report for Lisinopril
Formulation / Dosage : f.c. Tablet 12,5 / 25 mg f.c. Tablet 50 / 100 mg Therapeutical Use / ATC Code : Antihypertensive; C 9C Originator / Tradename : MSD / Lorzaar® Availability: SOLD Dossier/Status Report for Losartan
Formulation / Dosage : f.c. tablet 50+12,5 / 100+25 mg Therapeutical Use / ATC Code : Antihypertensive; C 9D Originator / Tradename : MSD / Lorzaar® Plus Availability: SOLD Dossier/Status Report for Losartan / HCT
Formulation / Dosage : tablet 2 mg / 0.035 mg Therapeutical Use / ATC Code : Antiacne; D 10B Contraceptive; G 3A Originator / Tradename : Schering / Diane® Availability: SOLD Dossier/Status Report for Cyproterone Acetate Ethinylestradiol
Formulation / Dosage : inj. solution 15 / 30 / 60 / 90 mg Therapeutical Use / ATC Code : Bone resorption inhibitor; M 5B Originator / Tradename : Novartis / Aredia® Availability: AVAILABLE Dossier/Status Report for Pamidronate
Formulation / Dosage : inj. emulsion 10 mg / ml Therapeutical Use / ATC Code : Anesthetic; N 1A Originator / Tradename : Astra Zeneca / Diprivan® Availability: SOLD Dossier/Status Report for Propofol
Formulation / Dosage : f.c. tablet 150 / 300 mg Therapeutical Use / ATC Code : Antibacterial; J 1F Originator / Tradename : Aventis / Rulid® Availability: SOLD Dossier/Status Report for Roxithromycin
Formulation / Dosage : f.c. tablet 10 / 20 / 40 mg Therapeutical Use / ATC Code : Antihyperlipidemic; C 10A Originator / Tradename : Merck&Co / Zocor® Availability: SOLD Dossier/Status Report for Simvastatin
Formulation / Dosage : capsule 0.4 mg Therapeutical Use / ATC Code : Benign prostatic hyperplasia; G 4C Originator / Tradename : Yamanouchi / Flomax® Availability: SOLD Dossier/Status Report for Tamsulosin
Formulation / Dosage : tablet 25 / 50 /100 / 200 mg Therapeutical Use / ATC Code : Anticonvulsant; N 3A Originator / Tradename : J & J / Topamax® Availability: SOLD Dossier/Status Report for Topiramate
Formulation / Dosage : inj. solution 25 / 50 / 100 mg Therapeutical Use / ATC Code : Antihypertensive; C 2A Originator / Tradename : Altana / Ebrantil® Availability: AVAILABLE Dossier/Status Report for Urapidil
Formulation / Dosage : tablet 250 / 500 / 1000 mg Therapeutical Use / ATC Code : Antiherpetic; J 5B Originator / Tradename : GSK / Valtrex® Availability: SOLD Dossier/Status Report for Valaciclovir
